[
1. Karastergiou K, Mohamed-Ali V. The autocrine and paracrine roles of adipokines. Mol Cell Endocrinol. 2010;318; DOI:10.1016/j.mce.2009.11.011.
]Open DOISearch in Google Scholar
[
2. Mancuso P. The role of adipokines in chronic inflammation. ImmunoTar-gets Ther. 2016;5; DOI:10.2147/ITT.S73223.
]Open DOISearch in Google Scholar
[
3. Frühbeck G, Catalán V, Rodrí guez A, Gómez-Ambrosi J. Adiponectin-leptin ratio: A promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk. Adipocyte. 2018;7; DOI:10.1080/21623945.2017.1402151.
]Open DOISearch in Google Scholar
[
4. Satoh N, Naruse M, Usui T, Tagami T, Suganami T, Yamada K, Kuzuya H, Shimatsu A, Ogawa Y. Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care. 2004;27; DOI:10.2337/diacare.27.10.2488.
]Open DOISearch in Google Scholar
[
5. Gutaj P, Sibiak R, Jankowski M, Awdi K, Bryl R, Mozdziak P, Kempisty B, Wender-Ozegowska E. The Role of the Adipokines in the Most Common Gestational Complications. Int J Mol Sci. 2020;21:9408; DOI:10.3390/ijms21249408.
]Open DOISearch in Google Scholar
[
6. Inuzuka H, Nishizawa H, Inagaki A, Suzuki M, Ota S, Miyamura H, Miyazaki J, Sekiya T, Kurahashi H, Udagawa Y. Decreased expression of apelin in placentas from severe pre-eclampsia patients. Hypertens Pregnancy. 2013;32; DOI:10.3109/10641955.2013.813535.
]Open DOISearch in Google Scholar
[
7. Couvineau P, Llorens-Cortes C, Iturrioz X. Elabela/Toddler and apelin bind differently to the apelin receptor. FASEB J. 2020;34:7989–8000; DOI:10.1096/fj.201903029R.
]Open DOISearch in Google Scholar
[
8. Ho L, Van Dijk M, Chye STJ, Messerschmidt DM, Chng SC, Ong S, Yi LK, Boussata S, Goh GHY, Afink GB, Lim CY, Dunn NR, Solter D, Knowles BB, Reversade B. ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice. Science (80-). 2017;357; DOI:10.1126/science.aam6607.
]Open DOISearch in Google Scholar
[
9. Zhou Q, Zhang K, Guo Y, Chen L, Li L. Elabela-APJ axis contributes to embryonic development and prevents pre-eclampsia in pregnancy. Acta Biochim Biophys Sin (Shanghai). 2018;50:319–21; DOI:10.1093/abbs/gmx143.
]Open DOISearch in Google Scholar
[
10. Hassan SS, Gomez-Lopez N. Reducing maternal mortality: can elabela help in this fight? Lancet. 2019;394:8–9; DOI:10.1016/S0140-6736(19)30543-4.
]Open DOISearch in Google Scholar
[
11. Ma J, Hu H, Lin M, Chen L, Liu M, Li H, Quan S. ELABELA alleviates syncytiotrophoblast hypoxia/reoxygenation injury and preeclampsia-like symptoms in mice by reducing apoptosis. Placenta. 2021;106:30–9; DOI:10.1016/j.placenta.2021.02.002.33610935
]Open DOISearch in Google Scholar
[
12. Georgiadou D, Boussata S, Ranzijn WHM, Root LEA, Hillenius S, bij de Weg JM, Abheiden CNH, de Boer MA, de Vries JIP, Vrijkotte TGM, Lam-balk CB, Kuijper EAM, Afink GB, van Dijk M. Peptide hormone ELABELA enhances extravillous trophoblast differentiation, but placenta is not the major source of circulating ELABELA in pregnancy. Sci Rep. 2019;9; DOI:10.1038/s41598-019-55650-5.691103931836787
]Open DOISearch in Google Scholar
[
13. Zhou L, Sun H, Cheng R, Fan X, Lai S, Deng C. ELABELA, as a potential diagnostic biomarker of preeclampsia, regulates abnormally shallow placentation via APJ. Am J Physiol Metab. 2019;316:E773–81; DOI:10.1152/ajpendo.00383.2018.30860880
]Open DOISearch in Google Scholar
[
14. Wang L, Zhang Y, Qu H, Xu F, Hu H, Zhang Q, Ye Y. Reduced ELABELA expression attenuates trophoblast invasion through the PI3K/AKT/mTOR pathway in early onset preeclampsia. Placenta. 2019;87:38–45; DOI:10.1016/j.placenta.2019.08.077.31546152
]Open DOISearch in Google Scholar
[
15. Wang X, Liang G, Guo Q, Cai W, Zhang X, Ni J, Tao Y, Niu X, Chen S. ELABELA improves endothelial cell function via the ELA–APJ axis by activating the PI3K/Akt signalling pathway in HUVECs and EA.hy926 cells. Clin Exp Pharmacol Physiol. 2020:1440-1681.13382; DOI:10.1111/1440-1681.13382.32687618
]Open DOISearch in Google Scholar
[
16. Huang R, Zhu J, Zhang L, Hua X, Ye W, Chen C, Sun K, Wang W, Feng L, Zhang J. Is ELABELA a reliable biomarker for hypertensive disorders of pregnancy? Pregnancy Hypertens. 2019;17:226–32; DOI:10.1016/j.preghy.2019.06.007.700177131487645
]Open DOISearch in Google Scholar
[
17. Hao S, You J, Chen L, Zhao H, Huang Y, Zheng L, Tian L, Maric I, Liu X, Li T, Bianco YK, Winn VD, Aghaeepour N, Gaudilliere B, Angst MS, Zhou X, Li Y-M, Mo L, Wong RJ, Shaw GM, Stevenson DK, Cohen HJ, Mcelhinney DB, Sylvester KG, Ling XB. Changes in pregnancy-related serum biomarkers early in gestation are associated with later development of preeclampsia. PLoS One. 2020;15:e0230000; DOI:10.1371/journal.pone.0230000.705375332126118
]Open DOISearch in Google Scholar
[
18. Ozgen G, Aydin GA, Ayvaci H. Predictive Role of First-trimester ELABELA Levels for Late-onset Preeclampsia. J Coll Physicians Surg Pakistan. 2021;31:916–20; DOI:10.29271/jcpsp.2021.08.916.34320707
]Open DOISearch in Google Scholar
[
19. Ma S, Guo C, Zhang J, Long S, Tan H, You Y, Chase PB. Association between ELABELA Serum Concentrations in First Trimester and Pregnancy-Induced Hypertension. Biomed Res Int. 2020;2020:1–5; DOI:10.1155/2020/2051701.753910133062670
]Open DOISearch in Google Scholar
[
20. Pritchard N, Kaitu’u-Lino TJ, Gong S, Dopierala J, Smith GCS, Charnock-Jones DS, Tong S. ELABELA/APELA Levels Are Not Decreased in the Maternal Circulation or Placenta among Women with Preeclampsia. Am J Pathol. 2018;188; DOI:10.1016/j.ajpath.2018.04.008.606399629803833
]Open DOISearch in Google Scholar
[
21. Panaitescu B, Romero R, Gomez-Lopez N, Pacora P, Erez O, Vadillo-Ortega F, Yeo L, Hassan SS, Hsu C-D. ELABELA plasma concentrations are increased in women with late-onset preeclampsia. J Matern Neonatal Med. 2020;33:5–15; DOI:10.1080/14767058.2018.1484089.634267529890874
]Open DOISearch in Google Scholar
[
22. Villie P, Lefevre G, Arrestier R, Rousseau A, Berkane N, Hertig A. ELABELA concentration is not decreased in maternal plasma before the onset of preeclampsia. Am J Obstet Gynecol. 2019;220:284–5; DOI:10.1016/j.ajog.2018.12.020.30576665
]Open DOISearch in Google Scholar
[
23. Para R, Romero R, Gomez-Lopez N, Tarca AL, Panaitescu B, Done B, Hsu R, Pacora P, Hsu CD. Maternal circulating concentrations of soluble Fas and Elabela in early- and late-onset preeclampsia. J Matern Neonatal Med. 2020; DOI:10.1080/14767058.2020.1716720.32008387
]Open DOISearch in Google Scholar
[
24. Deniz R, Baykus Y, Ustebay S, Ugur K, Yavuzkir Ş, Aydin S. Evaluation of elabela, apelin and nitric oxide findings in maternal blood of normal pregnant women, pregnant women with pre-eclampsia, severe pre-eclampsia and umbilical arteries and venules of newborns. J Obstet Gynaecol (Lahore). 2019;39; DOI:10.1080/01443615.2019.1572727.31064239
]Open DOISearch in Google Scholar
[
25. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care. 2010;33:676–82; DOI:10.2337/dc09-1848.282753020190296
]Open DOISearch in Google Scholar
[
26. Guo YY, Li T, Liu H, Tang L, Li YC, Hu HT, Su YF, Lin Y, Wang YY, Li C, Huang HF, Jin L, Liu XM. Circulating levels of Elabela and Apelin in the second and third trimesters of pregnancies with gestational diabetes mellitus. Gynecol Endocrinol. 2020; DOI:10.1080/09513590.2020.1739264.32208782
]Open DOISearch in Google Scholar
[
27. Karagoz ZK, Aydin S, Ugur K, Tigli A, Deniz R, Baykus Y, Sahin I, Yalcin MH, Yavuz A, Aksoy A, Aydin S. Molecular communication between Apelin-13, Apelin-36, Elabela, and nitric oxide in gestational diabetes mellitus. Eur Rev Med Pharmacol Sci. 2022;26:3289–300; DOI:10.26355/eurrev_202205_28748.35587081
]Open DOISearch in Google Scholar
[
28. Behram M, Oğlak SC, Dağ İ. Circulating levels of Elabela in pregnant women complicated with intrauterine growth restriction. J Gynecol Obstet Hum Reprod. 2021;50:102127; DOI:10.1016/j.jogoh.2021.102127.33781971
]Open DOISearch in Google Scholar
[
29. Yener G, Kavak SB, Gul Y, Celik Kavak E, Gulcu Bulmus F, Sanli C, Batmaz I, Bulu G. Elabela levels in pregnancies with intrauterine growth retardation. Ginekol Pol. 2022; DOI:10.5603/GP.a2021.0246.35315019
]Open DOISearch in Google Scholar
